Central Nervous System Activity Studies of Baptisia tinctoria (L.) R. Vent. Roots

Sujata,; Kumar, Deepak; Kumar, Suresh

doi:10.18052/www.scipress.com/IJPPE.6.1

IJPPE > IJPPE Volume 6 > Central Nervous System Activity Studies of...

< Back to Volume

Central Nervous System Activity Studies of Baptisia tinctoria (L.) R. Vent. Roots

Full Text PDF

Abstract:

The present investigations were undertaken with a view to evaluate Baptisia tinctoria roots (Wild Indigo; family – Fabaceae) systematically for neuropharmacological activities. The methanol extract (ME) of plant was prepared by extracting properly identified plant in a Soxhlet apparatus with methanol, after defatting with n-hexane. Acute toxicity studies revealed that ME is safe for acute administration. Preliminary phytochemical screening of ME showed presence of alkaloids, steroids, flavonoids, triterpenoids, coumarins and tannins as major classes of phytoconstituents. The ethyl acetate fraction (EAF) was prepared by fractionating crude ME using standardized procedure, which showed presence of flavonoids, alkaloids and triterpenoids. ME (400 mg/kg) and EAF (106 mg/kg) produced significant antistress activity in similar manner as exhibited by the standard drug. The ME and EAF exhibited mild antianxiety activity, and were found to be devoid of anticonvulsant, sedative and analgesic activities.

Info:

Periodical:

International Journal of Pharmacology, Phytochemistry and Ethnomedicine (Volume 6)

Pages:

1-7

DOI:

https://doi.org/10.18052/www.scipress.com/IJPPE.6.1

Citation:

Sujata et al., "Central Nervous System Activity Studies of Baptisia tinctoria (L.) R. Vent. Roots", International Journal of Pharmacology, Phytochemistry and Ethnomedicine, Vol. 6, pp. 1-7, 2017

Online since:

January 2017

Authors:

Sujata, Deepak Kumar, Suresh Kumar

Keywords:

Analgesic, Antianxiety, Anticonvulsant, Antistress, Sedative, Wild Indigo

Export:

RIS, BibTeX, Text

Distribution:

Open Access

This work is licensed under a
Creative Commons Attribution 4.0 International License

References:

[1] O. Prakash, D. Kumar, S. Kumar, Screening of methanol extract and ethyl acetate fraction of Abies webbiana Lindl. for neuropharmacological activities, Indian J. Pharm. Sci. 77 (2015) 536-541.

[2] B. Ghanashyam, S. Nagarathinam, India is failing the mentally ill as abuses continuing, Lancet. 376 (2010) 1633-1634.

[3] S. Sandhya, K.R. Vinod, S. Kumar, Herbs used for brain disorders, Hygeia J. Drugs Med. 2 (2010) 38-45.

[4] R.J. Baldessarini, Drugs and the treatment of psychiatric disorders, in: J.G. Hardman, L.E. Limbird (Eds. ), Goodman and Gilman's The Pharmacological Basis of Therapeutics, New York, McGraw- Hill, 2001, p.987.

[5] S. Noor et al., Evaluation of anti-inflammatory and antidiabetic activity of ethanolic extract of Desmodium pulchellum Benth (Fabaceae) barks on albino wistar rats, Journal of Applied Pharmaceutical Science. 3(7) (2013) 48-51.

[6] P. Bergner, Nervous depression and homeopathic indications of herbs, Med. Herb. 9 (1995) 12.

[7] W. Boericke, Homeopathic materia medica, Presented by Medi T, 1999, Information on: http: /www. homeoint. org/books/boericmm/b/bapt. html.

[8] J.W. Fyfe, The Essentials of modern materia medica and therapeutics, Eclectic Manual No. 6, Cincinnati, The Scudder Brothers Company, 1903, p.15.

[9] F.J. Petersen, Materia medica and clinical therapeutics, Published by F.J. California, Petersen Los Olivos, 1905, p.51.

[10] S. Tilgner, Wild Indigo: Baptisia tinctoria, Presented by Materia Medica, 1999, Information on: http: /www. herbaltransitions. com/materiamedica/Baptisia. html.

[11] A. Pengelly, K. Bennett, Appalachian plant monographs: Baptisia tinctoria (L. ) R. Vent., Wild Indigo, Maryland, Tai Sophia Institute, 2011, pp.1-15. Retrieved from http: /www. frostburg. edu/aces/appalachian-plants.

[12] N.R. Farnsworth, Biological and phytochemical screening of plants, J. Pharm. Sci. 55 (1966) 225-276.

[13] F. Sharmen et al., Investigation of in vivo neuropharmacological effects of Alpinia nigra leaf extract, Asian Pac. J. Trop. Biomed. 4 (2014) 137-142.

[14] W.C. Scheffer, Statistics for the Biological Sciences, Philippines, Addison-Wesley Publishing Company, 1980, pp.121-141.

[15] M. Komiya, T. Takeuchi, E. Harada, Lemon oil vapour causes an anti-stress effect via modulating the 5-HT and DA activities in mice, Behav. Brain Res. 172 (2006) 240-249.

[16] C. Belzung, G. Griebel, Measuring normal and pathological anxiety like behaviour in mice: A review, Behav. Brain Res. 152 (2001) 141-149.

[17] M.O. Raihan et al., Sedative and anxiolytic effects of the methanolic extract of Leea indica (Burm. f. ) Merr. Leaf, Drug Discov. Ther. 5 (2011) 185-189.

[18] E.A. Swinyard, W.C. Brown, L.S. Goodman, Comparative assays of antiepileptic drugs in mice and rats, J. Pharmacol. Exp. Ther. 3 (1952) 319-330.

[19] R. Madaan, S. Kumar, Screening of alkaloidal fraction of Conium maculatum Linn. aerial parts for analgesic and anti-inflammatory activity, Indian J. Pharm. Sci. 74 (2012) 457-460.

[20] C. Wolfman et al., Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora Coerulea, Pharmacol. Biochem. Behav. 47 (1994) 1-4.

[21] S. Kumar, A. Sharma, Apigenin: The anxiolytic constituent of Turnera aphrodisiaca, Pharm. Biol. 44 (2006) 84-90.

[22] L.T. Yi et al., Involvement of monoaminergic system in the antidepressant-like effect of the flavonoid naringenin in mice, Prog. Neuropsychopharmacol. Biol. Psychiatry. 34 (2010) 1223-1228.

[23] S.K. Kulkarni, A. Dhir, Berberine: A plant alkaloid with therapeutic potential for central nervous system disorders, Phytother. Res. 24 (2010) 317-324.

[24] H. Naaz et al., Anti-cholinergic alkaloids as potential therapeutic agents for Alzheimer's disease: An in silico approach, Indian J. Biochem. Biophys. 50 (2013) 120-125.

[25] Y. Qian et al., Maslinic acid, a natural triterpenoid compound from Olea europaea, protects cortical neurons against oxygen-glucose deprivation-induced injury, Eur. J. Pharmacol. 670 (2011) 148-153.

[26] R. Martin et al., Beneficial actions of oleanolic acid in an experimental model of multiple sclerosis: A potential therapeutic role, Biochem. Pharmacol. 79 (2010) 198-208.

Show More Hide

Cited By:

This article has no citations.